Skip to main content

T cell-targeted approaches to cancer immunotherapy

Special Collection Editor: Dr Adriana Bonomo, FIOCANCER, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil

Immunotherapy Advances features ongoing special collections on high-interest topics in immunotherapy throughout the year. This collection entitled ‘T cell-targeted approaches to cancer immunotherapy’ is led by Immunotherapy Advances’ Regional Editor for South America, Dr Adriana Bonomo, from FIOCANCER, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.

Submissions for this series are open throughout 2022. For more information on submitting your paper, please contact our Editorial Office at journals@immunology.org

Articles in collection

Figure from: Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer

REVIEW

Stephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan, Georgina H Mason, Awen M Gallimore, Andrew Godkin
 

REVIEW

Rafaela Rossetti, Heloísa Brand, Sarah Caroline Gomes Lima, Izadora Peter Furtado, Roberta Maraninchi Silveira, Daianne Maciely Carvalho Fantacini, Dimas Tadeu Covas, Lucas Eduardo Botelho de Souza
 

REVIEW

Dayane Schmidt, Sima Ebrahimabadi, Kauan Ribeiro de Sena Gomes, Graziela de Moura Aguiar, Mariane Cariati Tirapelle, Renata Nacasaki Silvestre, Júlia Teixeira Cottas de Azevedo, Dimas Tadeu Covas, Virginia Picanço-Castro
Figure from: Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
 

RESEARCH ARTICLE

D Tatovic, M A McAteer, J Barry, A Barrientos, K Rodríguez Terradillos, I Perera, E Kochba, Y Levin, M Dul, S A Coulman, J C Birchall, C von Ruhland, A Howell, R Stenson, M Alhadj Ali, S D Luzio, G Dunseath, W Y Cheung, G Holland, K May, J R Ingram, M M U Chowdhury, F S Wong, R Casas, C Dayan, J Ludvigsson
 

REVIEW

Guilherme Ferreira de Britto Evangelista, Amanda Braga Figueiredo, Milton José de Barros e Silva, Kenneth J Gollob
 
 

Submissions for this series are open throughout 2022. For more information on submitting your paper, please contact our Editorial Office at journals@immunology.org

Immunotherapy Advances welcomes original research, reviews, commentaries and TrialsWatch articles addressing a range of topics that contribute to our understanding of the immunotherapeutic treatment options for asthma and allergies.